Clinical Trial Update: Antisecretory Factor In Severe Traumatic Brain Injury [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial investigating antisecretory factor for severe traumatic brain injury. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Antisecretory Factor (antisecretory factor)

Snippet

Sponsor: Peter Siesjö | Conditions: Traumatic Brain Injury | Phase 2 | Status: RECRUITING